| Improving the power of diagnostics in the era of targeted therapy and personalized healthcare. | |
| | |
MedLine Citation:
|
PMID: 20205056 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The field of diagnostics has unprecedented opportunities to contribute to the practice of medicine in the era of targeted therapy and personalized healthcare. Rather than simply providing information regarding the presence and classification of disease, innovative molecular diagnostic tests will directly inform patient-management decisions, such as which targeted therapies to prescribe or whether a patient should be treated more aggressively. However, in order for diagnostics to deliver this high level of medical value, several challenges ranging from technical, pre-analytical, developmental, regulatory, reimbursement and quality perspectives need to be overcome. This review focuses on recent developments in each of these areas that are expected to improve the power and impact of diagnostics. |
| | |
Authors:
|
Eric E Walk |
Related Documents
:
|
10355456 - William carlos williams (1883-1963): physician-writer and "godfather of avant garde poe... 15233666 - Modeling our way toward the optimal management of variceal hemorrhage. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current opinion in drug discovery & development Volume: 13 ISSN: 2040-3437 ISO Abbreviation: Curr Opin Drug Discov Devel Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-03-05 Completed Date: 2010-06-04 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100887519 Medline TA: Curr Opin Drug Discov Devel Country: England |
Other Details:
|
Languages: eng Pagination: 226-34 Citation Subset: IM |
Affiliation:
|
Ventana Medical Systems Inc, Tucson, AZ 85755, USA. eric.walk@ventana.roche.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Drug Design Humans Molecular Diagnostic Techniques / methods*, trends* Mutation / genetics Neoplasms / diagnosis, genetics, therapy Pathology, Molecular Personal Health Services* / economics Pharmacogenetics / trends* Reimbursement Mechanisms |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Current and future treatments for relapsing-remitting multiple sclerosis.
Next Document: Novel therapeutics for Alzheimer's disease: an update.